<DOC>
	<DOCNO>NCT01109368</DOCNO>
	<brief_summary>This repository establish first time system carefully assess monitor time general health amount cholesterol arteries U.S. child adults homozygous familial hypercholesterolemia ( hoFH ) . Patients rare disorder high blood level cholesterol birth due inheritance abnormal gene parent . As result , untreated , heart attack sudden death occur childhood . Treatments LDL-apheresis liver transplant lower cholesterol level , best treatment best way monitor effect treatment artery unknown . The collection clinical data blood analysis know yet-to-be discovered marker predictor arterial disease yield new information natural history disorder response treatment . The repository greatly aid development specific protocol seek learn disease new therapy .</brief_summary>
	<brief_title>The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository</brief_title>
	<detailed_description>Detailed information `` standard care '' procedure compile database . These include medical history physical exam , lipid profile standard blood test , dietary evaluation counseling , cardiology evaluation include EKG echocardiogram , ultrasound carotids femoral artery , CT angiogram , indicate , intracoronary angiography ( ICA ) intravascular ultrasound ( IVUS ) stress echo nuclear stress test . The recommendation treatment individualize . Current option ) FDA approve cholesterol-lowering medication : statin , ezetimibe b ) LDL-apheresis c ) liver transplant ) portacaval shunt e ) investigational drug . Treatment vascular and/or valvular disease may include aspirin , beta blocker , clopidogrel , angioplasty metal stent , coronary artery bypass surgery , aortic valve repair/replacement . Research procedures include medical photo skin xanthoma , blood assay ( apolipoproteins A B , LDL particle size , homocysteine , TNF , IL-6 , insulin , glucose , ICAM , VCAM , P E selectin , endothelial progenitor cell ) , DNA analysis gene LDL receptor lipid-related gene .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients age sex meet clinical genetic criterion hoFH follow : Documented , untreated fasting LDL cholesterol level &gt; 500 mg/dL triglyceride &lt; 200 mg/dL cholesterollowering diet least 8 week secondary cause exclude , AND : DNA confirmation double mutation LDL receptor apoB gene OR LDL &gt; 160 mg/dL biological parent associate disorder know elevate LDL OR Coronary artery disease one parent grandparent &lt; 55 year male , &lt; 65 female OR Tendinous/cutaneous xanthoma &lt; age 10 coronary artery disease &lt; age 20 Exclusion criterion : 1 . Inability patient , , less 18 , parent , sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autosomal Dominant Familial Hypercholesterolemia</keyword>
</DOC>